These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14694037)

  • 1. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities.
    Feldmann R; Denecke J; Grenzebach M; Schuierer G; Weglage J
    Neurology; 2003 Dec; 61(12):1725-8. PubMed ID: 14694037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1.
    Feldmann R; Schuierer G; Wessel A; Neveling N; Weglage J
    Acta Paediatr; 2010 Nov; 99(11):1657-60. PubMed ID: 21039823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.
    Hyman SL; Gill DS; Shores EA; Steinberg A; North KN
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1088-91. PubMed ID: 17299016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.
    Hyman SL; Gill DS; Shores EA; Steinberg A; Joy P; Gibikote SV; North KN
    Neurology; 2003 Apr; 60(7):1139-45. PubMed ID: 12682321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
    Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
    Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: Are T2-weighted hyperintensities related to executive dysfunction?
    Roy A; Barbarot S; Charbonnier V; Gayet-Delacroix M; Stalder JF; Roulin JL; Le Gall D
    Neuropsychology; 2015 May; 29(3):473-84. PubMed ID: 25365565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year study.
    Payne JM; Pickering T; Porter M; Oates EC; Walia N; Prelog K; North KN
    Am J Med Genet A; 2014 Mar; 164A(3):661-5. PubMed ID: 24357578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
    Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
    Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence.
    Legius E; Descheemaeker MJ; Steyaert J; Spaepen A; Vlietinck R; Casaer P; Demaerel P; Fryns JP
    J Neurol Neurosurg Psychiatry; 1995 Dec; 59(6):638-40. PubMed ID: 7500107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning.
    Piscitelli O; Digilio MC; Capolino R; Longo D; Di Ciommo V
    Dev Med Child Neurol; 2012 Jan; 54(1):49-51. PubMed ID: 22107256
    [No Abstract]   [Full Text] [Related]  

  • 12. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
    Lorenzo J; Barton B; Arnold SS; North KN
    J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis.
    Moore BD; Slopis JM; Schomer D; Jackson EF; Levy BM
    Neurology; 1996 Jun; 46(6):1660-8. PubMed ID: 8649566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Key Search Subtest of the Behavioural Assessment of the Dysexecutive Syndrome in Children (BADS-C) Instrument Reveals Impaired Planning Without External Constraints in Children With Neurofibromatosis Type 1.
    Riva D; Vago C; Erbetta A; Saletti V; Esposito S; Micheli R; Bulgheroni S
    J Child Neurol; 2017 Mar; 32(4):387-396. PubMed ID: 28193119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of cognitive functioning, whole brain volumes, and T2-weighted hyperintensities in neurofibromatosis-1.
    Cutting LE; Koth CW; Burnette CP; Abrams MT; Kaufmann WE; Denckla MB
    J Child Neurol; 2000 Mar; 15(3):157-60. PubMed ID: 10757470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor impairment in children with Neurofibromatosis type 1: Effect of the comorbidity with language disorders.
    Iannuzzi S; Albaret JM; Chignac C; Faure-Marie N; Barry I; Karsenty C; Chaix Y
    Brain Dev; 2016 Feb; 38(2):181-7. PubMed ID: 26321374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive dysfunction in children with neurofibromatosis type 1: a study of action planning.
    Roy A; Roulin JL; Charbonnier V; Allain P; Fasotti L; Barbarot S; Stalder JF; Terrien A; Le Gall D
    J Int Neuropsychol Soc; 2010 Nov; 16(6):1056-63. PubMed ID: 20682087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.
    Descheemaeker MJ; Ghesquière P; Symons H; Fryns JP; Legius E
    J Intellect Disabil Res; 2005 Jan; 49(Pt 1):33-46. PubMed ID: 15634310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.
    Lidzba K; Granström S; Lindenau J; Mautner VF
    Dev Med Child Neurol; 2012 Oct; 54(10):892-7. PubMed ID: 22881119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is executive function specifically impaired in children with neurofibromatosis type 1? A neuropsychological investigation of cognitive flexibility.
    Roy A; Barbarot S; Roulin JL; Charbonnier V; Fasotti L; Stalder JF; Le Gall D
    Appl Neuropsychol Child; 2014; 3(2):94-102. PubMed ID: 24716868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.